[18F]JZP-MA-11

N/A

Report date: 2022/12/16 15:21:54

Base Information

Drug Name[18F]JZP-MA-11
Drug Alias Name[18F]JZP-MA-11
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agent
Mechanisms of ActionPositron-emission tomography enhancers
TargetsMonoacylglycerol lipase ABHD6
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Helsinki
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Helsinki
Inactive CompaniesN/A
Active IndicationsNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A